Bearish
NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit
The Rosen Law Firm is reminding purchasers of Nektar Therapeutics (NASDAQ: NKTR) securities that the lead plaintiff deadline for a securities fraud la...